Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2014 08:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Reports 2013 Fourth Quarter and Year-End Financial Results

2013 Key Highlights Include: Strong cash position of over $34 million, as of February 2014, following two private placements in early 2014 and the exercise of warrants, including by directors...